ATE241969T1 - Tabletten mit einem kern, der mit einem pilzbekämpfungsmittel und einem polymeren beschichtet ist - Google Patents

Tabletten mit einem kern, der mit einem pilzbekämpfungsmittel und einem polymeren beschichtet ist

Info

Publication number
ATE241969T1
ATE241969T1 AT98919155T AT98919155T ATE241969T1 AT E241969 T1 ATE241969 T1 AT E241969T1 AT 98919155 T AT98919155 T AT 98919155T AT 98919155 T AT98919155 T AT 98919155T AT E241969 T1 ATE241969 T1 AT E241969T1
Authority
AT
Austria
Prior art keywords
antifungal
tablets
polymer
core coated
coated
Prior art date
Application number
AT98919155T
Other languages
German (de)
English (en)
Inventor
Roger Petrus Gerebe Vandecruys
Conde Valentin Florent Vict De
Paul Marie Victor Gilis
Jozef Peeters
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE241969T1 publication Critical patent/ATE241969T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT98919155T 1997-03-26 1998-03-18 Tabletten mit einem kern, der mit einem pilzbekämpfungsmittel und einem polymeren beschichtet ist ATE241969T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97200914 1997-03-26
PCT/EP1998/001773 WO1998042318A1 (en) 1997-03-26 1998-03-18 Pellets having a core coated with an antifungal and a polymer

Publications (1)

Publication Number Publication Date
ATE241969T1 true ATE241969T1 (de) 2003-06-15

Family

ID=8228147

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98919155T ATE241969T1 (de) 1997-03-26 1998-03-18 Tabletten mit einem kern, der mit einem pilzbekämpfungsmittel und einem polymeren beschichtet ist

Country Status (30)

Country Link
EP (1) EP0969821B1 (enExample)
JP (1) JP3608800B2 (enExample)
KR (1) KR100520936B1 (enExample)
CN (1) CN1206984C (enExample)
AP (1) AP1227A (enExample)
AT (1) ATE241969T1 (enExample)
AU (1) AU734248B2 (enExample)
BG (1) BG64434B1 (enExample)
BR (1) BR9806174A (enExample)
CA (1) CA2269501C (enExample)
CY (1) CY2384B1 (enExample)
CZ (1) CZ295502B6 (enExample)
DE (1) DE69815316T2 (enExample)
DK (1) DK0969821T3 (enExample)
EE (1) EE03904B1 (enExample)
ES (1) ES2201485T3 (enExample)
HU (1) HU224217B1 (enExample)
ID (1) ID21477A (enExample)
IL (1) IL129575A (enExample)
NO (1) NO325102B1 (enExample)
NZ (1) NZ335364A (enExample)
OA (1) OA11162A (enExample)
PL (1) PL190566B1 (enExample)
PT (1) PT969821E (enExample)
RU (1) RU2218153C2 (enExample)
SI (1) SI0969821T1 (enExample)
SK (1) SK284813B6 (enExample)
TR (1) TR199900990T2 (enExample)
UA (1) UA60318C2 (enExample)
WO (1) WO1998042318A1 (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL137665A0 (en) * 1998-07-17 2001-10-31 Janssen Pharmaceutica Nv Pellets having core coated with an antifungal and a polymer
ES2157731B1 (es) 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
DK1163234T3 (da) 1999-03-24 2006-02-27 Scherer Technologies Inc R P Farmaceutiske formuleringer med forbedret vandoplöselighed
KR100432949B1 (ko) * 2000-06-13 2004-05-31 코오롱제약주식회사 생체이용율이 향상된 이트라코나졸의 분립체 조성물과이를 이용한 이트라코나졸 제제 및 그 제조방법
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
SK287582B6 (sk) 2001-02-14 2011-03-04 Tibotec Pharmaceuticals Ltd. 2-(Substituovaná amino)benztiazolsulfonamidová zlúčenina, spôsob jej prípravy, použitie a farmaceutická zmes s jej obsahom
WO2002081478A2 (en) 2001-04-09 2002-10-17 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
BR0209594A (pt) 2001-05-11 2004-03-30 Tibotec Pharm Ltd Inibidores de protease de hiv de amplo espectro de 2-amino-benzoxazol sulfonamida
WO2002100407A1 (en) * 2001-06-12 2002-12-19 Smartrix Technologies Inc. Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
US8071133B2 (en) 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
HRP20040662B1 (hr) 2001-12-21 2013-12-06 Tibotec Pharmaceuticals Ltd. Sulfonamidi koji sadrže heterociklički supstituirani fenil kao inhibitori hiv proteaze širokog spektra
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
SI1517899T1 (sl) 2002-05-17 2008-02-29 Tibotec Pharm Ltd Substituirani benzoksazol sulfonamidi sirokega spektra, ki so HIV proteazni inhibitorji
BR0305771A (pt) 2002-08-14 2004-10-05 Tibotec Pharm Ltd Inibidores de protease do hiv oxindol sulfonamida substituìdos de amplo espectro
KR100557680B1 (ko) * 2002-11-23 2006-03-07 한국유나이티드제약 주식회사 이트라코나졸의 용해도 개선을 위한 펠렛제제 및 그제조방법
SI1438960T2 (sl) * 2003-01-14 2013-04-30 Cimex Pharma Ag Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljšano biorazpoložljivostjo
DE60312636T3 (de) * 2003-01-14 2014-12-24 Acino Pharma Ag Bioaequivalente Zusammensetzung in der Form einer festen Dispersion enthaltend Itraconazol und ein hydrophiles Polymer
NZ545145A (en) * 2003-08-06 2009-07-31 Nirmal Mulye Pharmaceutical composition containing water soluble drug
CN1849117B (zh) 2003-09-11 2010-05-26 泰博特克药品有限公司 Hiv病毒的侵入抑制剂
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
AR048650A1 (es) 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
AU2005244121B2 (en) 2004-05-07 2012-01-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
US7622582B2 (en) 2004-05-17 2009-11-24 Tibotec Bvba Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one
TW200607502A (en) 2004-05-17 2006-03-01 Tibotec Pharm Ltd 6, 7, 8, 9-substituted 1-phenyl-1, 5-dihydro-pyrido[3, 2-b]indol-2-ones
MXPA06013314A (es) 2004-05-17 2007-02-02 Tibotec Pharm Ltd 1-heterociclil-1,5-dihidro-pirido[3,2-b]indol-2-onas.
WO2007113290A1 (en) 2006-04-03 2007-10-11 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones
BRPI0716481A2 (pt) * 2006-09-04 2014-03-18 Panacea Biotec Ltd Tecnologia de liberação flutuante programável
KR100809903B1 (ko) * 2006-09-05 2008-03-06 주식회사유한양행 안정화된 클로피도그렐-함유 입자, 그의 제조방법, 및 이를포함하는 약학 조성물
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
JP2008280254A (ja) * 2007-05-08 2008-11-20 Everest Pharm Industrial Co Ltd 生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物
US8313527B2 (en) 2007-11-05 2012-11-20 Allergan, Inc. Soft prosthesis shell texturing method
CN101965186A (zh) 2007-11-28 2011-02-02 塞阔伊亚药品公司 抑制细胞色素p450 2d6的化合物和方法
CA2716348C (en) 2008-02-21 2017-04-04 Sequoia Pharmaceuticals, Inc. Diamide inhibitors of cytochrome p450
US9050184B2 (en) 2008-08-13 2015-06-09 Allergan, Inc. Dual plane breast implant
US8877822B2 (en) 2010-09-28 2014-11-04 Allergan, Inc. Porogen compositions, methods of making and uses
US9205577B2 (en) 2010-02-05 2015-12-08 Allergan, Inc. Porogen compositions, methods of making and uses
US9138309B2 (en) 2010-02-05 2015-09-22 Allergan, Inc. Porous materials, methods of making and uses
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
US11202853B2 (en) 2010-05-11 2021-12-21 Allergan, Inc. Porogen compositions, methods of making and uses
EP2569021B1 (en) * 2010-05-11 2017-01-04 Allergan, Inc. Porogen compositions, methods of making and uses
US8679279B2 (en) 2010-11-16 2014-03-25 Allergan, Inc. Methods for creating foam-like texture
CN102100678B (zh) * 2011-02-18 2012-10-17 天津力生制药股份有限公司 伊曲康唑硫酸盐微丸及其制备方法
CA2895083A1 (en) 2012-12-13 2014-06-19 Allergan, Inc. Device and method for making a variable surface breast implant
US10092392B2 (en) 2014-05-16 2018-10-09 Allergan, Inc. Textured breast implant and methods of making same
WO2017127073A1 (en) * 2016-01-20 2017-07-27 Theravida, Inc. Methods and compositions for treating hyperhidrosis
DK3781132T3 (da) * 2018-04-16 2024-04-22 Bristol Myers Squibb Co Apixabanformuleringer
CN114767636B (zh) * 2022-04-11 2023-11-07 苏州中化药品工业有限公司 伊曲康唑微丸、制备方法及伊曲康唑微丸胶囊

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
USH672H (en) * 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
EP0374531B1 (en) * 1988-12-22 1994-05-04 American Cyanamid Company Method for the treatment of periodontal disease by sustained delivery of a therapeutic agent to the periodontal pocket, composition of matter therefor and apparatus for the administration thereof
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
CN1228693A (zh) * 1996-06-28 1999-09-15 先灵公司 含有三唑类抗真菌化合物的口服组合物

Also Published As

Publication number Publication date
RU2218153C2 (ru) 2003-12-10
CA2269501A1 (en) 1998-10-01
SI0969821T1 (en) 2003-10-31
IL129575A0 (en) 2000-02-29
TR199900990T2 (xx) 1999-10-21
ES2201485T3 (es) 2004-03-16
AU734248B2 (en) 2001-06-07
CN1206984C (zh) 2005-06-22
AP1227A (en) 2003-11-24
OA11162A (en) 2003-04-16
CA2269501C (en) 2005-11-08
NO992114D0 (no) 1999-04-30
NO325102B1 (no) 2008-02-04
NO992114L (no) 1999-08-26
PL190566B1 (pl) 2005-12-30
KR20000052971A (ko) 2000-08-25
EP0969821A1 (en) 2000-01-12
IL129575A (en) 2004-06-20
SK284813B6 (sk) 2005-12-01
HUP0002056A3 (en) 2001-01-29
EE9900453A (et) 2000-04-17
PL335542A1 (en) 2000-04-25
HU224217B1 (hu) 2005-06-28
ID21477A (id) 1999-06-17
JP2001520663A (ja) 2001-10-30
EP0969821B1 (en) 2003-06-04
SK54499A3 (en) 2000-01-18
CY2384B1 (en) 2004-06-04
KR100520936B1 (ko) 2005-10-17
AP9901516A0 (en) 1999-06-30
WO1998042318A1 (en) 1998-10-01
NZ335364A (en) 2000-08-25
PT969821E (pt) 2003-10-31
EE03904B1 (et) 2002-12-16
DE69815316T2 (de) 2004-04-29
DE69815316D1 (de) 2003-07-10
CZ295502B6 (cs) 2005-08-17
BG64434B1 (en) 2005-02-28
CZ139899A3 (cs) 1999-10-13
BR9806174A (pt) 1999-10-19
JP3608800B2 (ja) 2005-01-12
CN1244796A (zh) 2000-02-16
AU7210798A (en) 1998-10-20
HK1022840A1 (en) 2000-08-25
BG103356A (en) 2000-03-31
HUP0002056A2 (hu) 2000-12-28
DK0969821T3 (da) 2003-09-15
UA60318C2 (uk) 2003-10-15

Similar Documents

Publication Publication Date Title
ATE241969T1 (de) Tabletten mit einem kern, der mit einem pilzbekämpfungsmittel und einem polymeren beschichtet ist
GR3022198T3 (en) Beads having a core coated with an antifungal and a polymer.
IL137665A0 (en) Pellets having core coated with an antifungal and a polymer
ATE223706T1 (de) Tabletten enthaltend amoxicillin und clavulanate, die mit einem polymerüberzug versehen sind
DE69801955D1 (de) Behälter mit einem Schlitzventil
DE69816601D1 (de) Konjugierte polymer in einem oxidierten zustand
SK2738U (sk) Polymérny materiál a jeho použitie
DE69422976D1 (de) Ausgabevorrichtung versehen mit einem Rückschlagventil
DE69413097D1 (de) Gegenstand mit lichtstreuender Beschichtung, Herstellung und Gebrauch
AU1882599A (en) Multilayer structure comprising a material coated with block polyamide and blockhydrophilic copolymers
DE69607744D1 (de) Material mit einer beschichtung aus einem polyurethan- polyharnstoff polymer hydrogel
DE69701710D1 (de) Verbundrohr mit einem gewickelten Kern
GB2345285B (en) Photoresist cross-linking monomers,photoresist polymers and photoresist compos itions comprising the same
DE69408317D1 (de) Anhydrid-epoxy überzugszusammensetzung, modifiziert mit einem fluorpolymer
PL358909A1 (en) Pellets having a core coated with a lipid lowering agent and a polymer
DE69803410D1 (de) Mit einem haftklebemittel beschichtetes schlingenmaterial ohne trennschicht
DE69702940D1 (de) Mit einem Desinfektionsmittel imprägnierte Träger
FI960871L (fi) Vinyyliaromaattista polymeeriä, polyolefiiniä ja kahta lineaarista kopolymeeriä käsittävä koostumus
HK1032918A (en) Pellets having a core coated with a lipid lowering agent and a polymer
FI973739A0 (fi) Palonkestävyydeltään parannettu kerrosrakenne ja menetelmä rakenteen valmistamiseksi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0969821

Country of ref document: EP